Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2016

A summary of the warrant activity during the years ended December 31, 2016 and 2015 is presented below:

	Number of Warrants			Weighted Average Exercise Price			Weighted Average Remaining Life

Outstanding January 1, 2016		9,506,304		$	4.93			1.5
Granted		190,500			1.35			7.0
Exercised		-			-
Forfeited		(474,772	)		(2.63	)		-
Outstanding December 31, 2016		9,222,032		$	4.98			1.7

Exercisable December 31, 2016		9,222,032		$	4.98			1.7

Schedule of Warrants Outstanding

Exercise Price	Outstanding Number of Warrants		Weighted Average Remaining Life in Years		Exerciseable Number of Warrants


> $4.00		7,439,631		1.5		7,439,631
$3.00-$3.99		499,901		2.6		499,901
$2.00-$2.99		779,500		3.1		779,500
$1.00-$1.99		503,000		4.3		503,000
		9,222,032				9,222,032

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details